A previous study showed that CaMKKβ was involved in the activation of AMPK when vascular endothelial growth factor B inhibited adipogenesis in mice with NAFLD [25]. The gene discussed is VEGFB; the disease is metabolic dysfunction-associated steatotic liver disease.